The Kidney Foundation of Canada

ASF, PEDERSEN FAMILY, KFOC ALPORT SYNDROME RESEARCH FUNDING PROGRAM

GUIDELINES:

Letter of Intent Guidelines

Policy on Indirect Costs of Research

The Art of Grantsmanship: (Helpful pointers on preparing funding applications.)

 

DEADLINE:  Letter of Intent - Friday, February 9, 2018 (5:00 PM Arizona time/MST)

Only applications in English will be accepted.


The principal goal of the Alport Syndrome Foundation, Inc. (ASF), Pedersen Family and The Kidney Foundation of Canada (KFOC) Funding Program is to find novel treatments to prevent kidney failure and hearing loss in all patients with Alport Syndrome.

Types of Proposals Sought

Research proposals with the potential to accelerate the development of new treatments to prolong kidney function and prevent hearing loss including:

•    Identification and investigation of target pathways in disease progression
•    Drug repurposing or other novel approaches to improve the current standard of care.

Funding

It is anticipated that two research projects will be selected for funding, totaling $100,000 USD each, over a one- to two-year timeframe. Successful applicants will be notified in June 2018 in accordance with the ASF, Pedersen Family, KFOC Alport Syndrome Research Funding Program. There are no geographical limitations of this funding.

Process

Letters of intent (LoIs) will be evaluated by an independent peer review process. LoIs should be no longer than 2 pages in length and must be in accordance with the instructions in the ASF, Pedersen Family, KFOC Alport Syndrome Research Funding Program. Authors of the LoIs found to have the best merit for funding will be invited to submit a full proposal application 10–15 pages in length for further independent peer review. Final grant recipients will be selected from this pool. The detailed schedule and instructions can be found here: Letter of Intent Guidelines

Deadline

The deadline for submission of a letter of intent is Friday, February 9, 2018 by 5:00 pm Arizona Time/MST (no late submittals will be accepted).

For Additional Information, go to www.alportsyndrome.org or Contact:

Gina Parziale
Executive Director, Alport Syndrome Foundation, Inc.
Telephone:  1-480-800-3510
Email:  research@alportsyndrome.org

Or

Elisabeth Fowler
National Director of Research, The Kidney Foundation of Canada
Telephone:  613-793-1299
Email:  elisabeth.fowler@kidney.ca
Website: www.kidney.ca

Only applications in English will be accepted.